NIH-funded research R01 grant

Identifying gene markers for airway disease and COPD treatment response

Official title: Defining a gene expression signature of airway disease, COPD exacerbations, and response to treatment

Funded at Brigham and Women's Hospital · NIH-11088732 · Data updated 2026-11-12

This study is looking at how your genes might affect your COPD and how well you respond to treatments like inhaled steroids, so we can find better ways to personalize your care and help manage your symptoms more effectively.

More COPD research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBrigham and Women's Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startJune 1, 2023
Project endMay 31, 2027
Funding year2025
Award (this year)$832,016
NIH project number5R01HL166231-03
Project IDNIH-11088732 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with chronic obstructive pulmonary disease (COPD) who are experiencing exacerbations or are undergoing treatment.

Less likely to help

Patients with mild respiratory issues or those without a COPD diagnosis may not benefit from this research.

What this research studies

This research investigates the genetic factors that influence chronic obstructive pulmonary disease (COPD) and how patients respond to treatments like inhaled corticosteroids. By analyzing blood samples from participants in a long-term study, researchers aim to identify specific gene expression patterns that correlate with disease severity and treatment outcomes. The goal is to develop predictive models that can help tailor treatments based on individual genetic profiles, potentially improving management of COPD exacerbations and progression.

Why it matters

Potential benefit: If successful, this research could lead to more personalized treatment strategies for COPD patients, improving their health outcomes and quality of life.

How similar studies have gone: Previous research has shown promise in using genetic markers to predict treatment responses in other diseases, suggesting potential success for this approach in COPD.

Where this research is happening

  • Brigham and Women's Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Hersh, Craig P — Brigham and Women's Hospital
  • Study coordinator: Hersh, Craig P

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.